Summary

Fortis Healthcare, a leading healthcare delivery company in India, announced its unaudited consolidated financial results for the quarter ended June 30, 2025. The company reported a 16.6% increase in consolidated revenues, reaching INR 2,167 Cr. The operating EBITDA margin stood at 22.6%, up from 18.4% in Q1 FY25. The hospital business revenues were INR 1,838 Cr, up 18.6%, with an operating EBITDA margin of 22.1%. The diagnostic business revenues (net) were INR 329 Cr, up 6.3% from Q1 FY25.

Key Highlights

1. 1

   Consolidated revenues at INR 2,167 Cr, up 16.6%

2. 2

   Operating EBITDA margin at 22.6% (vs Q1 FY25 at 18.4%)

3. 3

   Hospital Business Revenues at INR 1,838 Cr, up 18.6%

4. 4

   Operating EBITDA margin at 22.1% (vs Q1 FY25 at 18.5%)

5. 5

   Diagnostic Business (INR Cr) aiFy25 | aiFy26 | Change | aaryas | % Change Revenue (net) 309 329 6.3% 306 7.3%

6. 6

   Company further expands its footprint in key metro cities with an O&M Services agreement with Gleneagles India Gurugram

7. 7

   Net debt to EBITDA of 0.92x as compared to 0.22x as on 30th June 2024

8. 8

   Occupancy 67% 69% 69% ARPOB (INR/Cr p.a.) 2.41 2.65 2.51 ALOS (Days) 4.16 4.09 4.22

9. 9

   International Patient revenues grew 21% to INR 154 Cr in Q1 FY26 vs INR 127 Cr in Q1 FY25

10. 10

    Key surgical procedure volumes performed across some of our focus specialties such as Robotic Surgeries, Radiation Therapy and Ortho Procedures increased by 75%, 53% and 22% YoY

11. 11

    Q1 FY26 diagnostic business gross revenue grew 7.4% to INR 368.8 Cr compared to INR 343.5 Cr in Q1 FY25

12. 12

    Operating EBITDA margins (basis gross revenues) stood at 23.0% versus 16.1% in Q1 FY25